NCT03530852View on ClinicalTrials.gov

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2028

Conditions
Short Bowel SyndromeMalabsorption
Interventions
DEVICE

Relizorb

Tube feeds run across device to digest fats.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Alcresta Therapeutics, Inc.

INDUSTRY

lead

Boston Children's Hospital

OTHER